Mini-symposium: Childhood TB in 2010New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects
Introduction
Globally, under diagnosis of childhood pulmonary tuberculosis (PTB) remains an obstacle to effective management. TB control programmes still focus predominantly on the diagnosis and cure of cases of smear-positive adult TB, as these are the major drivers of TB transmission. Whilst adult TB cases are often easily recognizable, due to typical radiological features and a positive sputum smear, childhood TB is frequently more difficult to diagnose. The clinical and radiological features of childhood TB are often non-specific and subject to variable interpretation.1 Structured diagnostic scoring systems based on clinical and radiological findings and tuberculin skin testing (TST) show high variability in case yield and very poor agreement.2
The diagnosis is even more problematic in HIV-infected children, since clinical and radiological features overlap with other infections and anergy to the TST is common.3 Clinical scoring systems have not been adequately evaluated in HIV-infected children, but it is likely that their performance will be even poorer in this patient population.
Microbiologic confirmation of PTB is still rarely attempted in children, especially in primary care settings, in contrast to adults where this is the accepted standard of care. This is due to the incorrect perception that respiratory specimens are difficult or impossible to obtain in children, the lack of infrastructure or trained staff to obtain such specimens and the lack of policy regarding microbiologic confirmation in children. However, even when samples can be obtained, since disease is typically paucibacillary, the yield of direct acid-fast smear microscopy is very low4 and prolonged mycobacterial culture is required. As a result, microbiological confirmation may be delayed by weeks. This has important implications for a disease that may progress rapidly in young children, with associated morbidity and mortality. Extra-pulmonary TB is common in young children and poses particular challenges for specimen collection and culture.
The major advantages of obtaining microbiological confirmation are the ability to make a definitive diagnosis and to perform drug susceptibility testing to exclude drug-resistant TB. In the era of increasing multidrug resistant (MDR) and extensively drug resistant (XDR) TB this information becomes critical in order to guide appropriate therapy.
However, mycobacterial culture is frequently negative in children with clinically diagnosed PTB, particularly amongst less ill patients in a primary care setting.5 This may represent the poor specificity of clinical diagnosis or alternatively, the impaired sensitivity of culture for childhood TB. This presents a fundamental problem in assessing the performance of any novel diagnostic test or clinical algorithm as there is no reference standard which is both highly sensitive and specific to which results can be compared. A further implication is that clinicians are often wary to discontinue TB therapy when a negative culture result is obtained.
This review will address the progress made in recent years in obtaining laboratory confirmation of PTB in children. The diagnosis of latent TB infection and the use of serological tests and interferon-gamma release assays are considered elsewhere in this edition.
Section snippets
Obtaining representative specimens from the lower respiratory tract of children
Microbiological confirmation of TB in young children is not routinely attempted in many high burden settings due to the difficulty in obtaining samples and the poor performance of smear microscopy. However, if facilities for mycobacterial culture and drug susceptibility testing are available, such confirmation is invaluable.
Since young children are frequently unable to expectorate, additional procedures are often required to obtain samples from the lower respiratory tract. For many years the
Improvements in smear microscopy(Level A)
There have been incremental advances in the performance of smear microscopy for the rapid detection of MTB. It is clear that concentration of specimens by centrifugation18 and the use of fluorescent microscopy19 increase the yield of smear microscopy [Table 1]. Until recently, one of the drawbacks of fluorescent microscopy has been the need for a costly, short-lived mercury vapour light source. The recent availability of low cost, long-lived light emitting diode (LED) light sources for
Improvements in culture techniques
There is no doubt that liquid culture systems with continuous monitoring for mycobacterial growth (such as MB/BacT [Biomerieux, Marcy l’Etoile, France], BACTEC 9000 [Becton Dickinson, NJ, USA] and the mycobacterial growth indicator tube [MGIT; Becton Dickinson]) are a significant advance over solid culture (typically Löwenstein Jensen, LJ) [Table 1]. In adult studies, mean time to detection is substantially lower for automated liquid culture (13.2 vs. 25.8 days for MGIT vs. LJ in a recent
Detection of M. tuberculosis nucleic acid
Whilst detection of live MTB is likely to remain the gold-standard for diagnosis in the immediate future, nucleic acid amplification assays (NAA) for the detection of MTB DNA or RNA are finally coming of age. There are obvious attractions to NAA. These assays are theoretically highly sensitive, able to detect very low copy numbers of nucleic acid, rapid (results typically available on the same day), may not require biosafety level 3 facilities and hence may be deployed closer to the point of
Other tests
There are two novel diagnostic modalities which have not, to our knowledge, been evaluated in children, but which are likely to be tested in this population in the near future; the urinary lipoarabinomannan (LAM) assay and tests for volatile organic compounds in the breath. The LAM assay is an ELISA-based test for a mycobacterial glycolipid. The sensitivity of urine LAM testing for adult disease has varied widely (44%-67%)38, 39 with the higher estimates in HIV co-infected patients with
Conclusion
Advances in the diagnosis of childhood TB in the past decade have included the identification of alternative specimen types such as induced sputum and nasopharyngeal aspirate as well as improvements in smear microscopy and liquid culture systems. A number of novel and exciting candidates have been identified for diagnosis of adult TB, such as integrated real-time PCR detection systems, urine LAM and testing for volatile organic compounds in breath. There is a clear need for a large, prospective
Funding sources
Mark Nicol is funded for TB research by the Wellcome Trust, EDCTP, NIH, the NHLS research Trust and South African MRC. The funding sources did not play any role in the writing of this manuscript.
Heather Zar is funded for TB research by the NIH, USA, EDCTP, MRC, South Africa and National Research Foundation, South Africa. The funding sources did not play any role in the writing of this manuscript.
Educational Aims
- •
To describe current state-of-the-art for diagnosis of pulmonary tuberculosis in children
- •
To discuss the advantages and limitations of various specimen types for diagnosis of pulmonary tuberculosis in children
- •
To discuss the role and limitations of nucleic acid amplification assays in the diagnosis of pulmonary tuberculosis in children
Practice Points
For diagnosis of pulmonary tuberculosis in children:
- •
Microbiological confirmation should be sought
- •
Sputum induction is a safe procedure with a high diagnostic yield
- •
Samples should be processed by chemical lysis of sputum, centrifugation, fluorescent microscopy and liquid culture
- •
The results of ‘in-house’ nucleic acid amplification assays should be interpreted with caution and such assays require rigorous clinical evaluation prior to use
Research Directions
- •
The performance of novel integrated nucleic acid amplification systems (such as GeneXpert) for the diagnosis of pulmonary tuberculosis in children
- •
The utility of nasopharyngeal aspiration for the diagnosis of pulmonary tuberculosis in children
References (42)
Global paediatric pulmonology: out of Africa
Paediatr Respir Rev.
(2006)- et al.
Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study
Lancet.
(2005) - et al.
Detection of Mycobacterium tuberculosis in nasopharyngeal aspirate samples in children
Lancet.
(1998) - et al.
Diagnosis of sputum-scarce HIV-associated pulmonary tuberculosis in Lima, Peru
Lancet.
(2005) - et al.
Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review
Lancet Infect Dis.
(2006) - et al.
Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review
Lancet Infect Dis.
(2006) - et al.
Use of polymerase chain reaction for improved diagnosis of tuberculosis in children
J Pediatr.
(1995) - et al.
Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods
Lancet Infect Dis.
(2009) - et al.
Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis
Trans R Soc Trop Med Hyg.
(2005) - et al.
Volatile biomarkers of pulmonary tuberculosis in the breath
Tuberculosis (Edinb).
(2007)
Diagnostic accuracy of chest radiography in detecting mediastinal lymphadenopathy in suspected pulmonary tuberculosis
Arch Dis Child.
Structured approaches for the screening and diagnosis of childhood tuberculosis in a high prevalence region of South Africa
Bull World Health Organ.
Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis?
Arch Dis Child.
Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa
Arch Dis Child.
Sputum induction as a diagnostic tool for community-acquired pneumonia in infants and young children from a high HIV prevalence area
Pediatr Pulmonol.
Nasopharyngeal aspiration for diagnosis of pulmonary tuberculosis
Arch Dis Child.
Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method
Pediatrics.
Multiple sampling in one day to optimize smear microscopy in children with tuberculosis in Yemen
PLoS One.
La cuerda dulce--a tolerability and acceptability study of a novel approach to specimen collection for diagnosis of paediatric pulmonary tuberculosis
BMC Infect Dis.
Reducing the string test intra-gastric downtime for detection of Mycobacterium tuberculosis
Int J Tuberc Lung Dis.
Cited by (127)
Vascular endothelial growth factor (VEGF) and interleukin-1 receptor antagonist (IL-1Ra) as promising biomarkers for distinguishing active from latent tuberculosis in children and adolescents
2022, TuberculosisCitation Excerpt :Unfortunately, we were not able to assess IFN-γ levels. Nevertheless, this cytokine is already used as a biomarker for LTBI diagnosis [4,6]; however, its use is limited in children under 5 years-old, because of low sensitivity and lower IFN-γ production [21]. In this study, we observed that VEGF and IL-1Ra showed higher efficacy in distinguishing PTB from LTBI regardless of age.
Respiratory Complications in Children and Adolescents with Human Immunodeficiency Virus
2021, Pediatric Clinics of North AmericaAdvances in the diagnosis of pulmonary tuberculosis in children
2020, Paediatric Respiratory ReviewsCitation Excerpt :Most PTB diagnoses in children globally are made on clinical and radiological evidence, and microbiological confirmation remains unusual [1]. The reasons for the difficulty in confirming a diagnosis of PTB in children are well-described [2,3]. Both clinical features and radiological findings are frequently non-specific or subtle, particularly in children with less severe illness [4,5].